AxoGen ROE 2010-2024 | AXGN
Current and historical return on equity (ROE) values for AxoGen (AXGN) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| AxoGen ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-12-31 | $-0.01B | $0.10B | -11.22% |
| 2024-09-30 | $-0.02B | $0.10B | -15.63% |
| 2024-06-30 | $-0.02B | $0.10B | -17.75% |
| 2024-03-31 | $-0.02B | $0.09B | -22.92% |
| 2023-12-31 | $-0.02B | $0.10B | -22.62% |
| 2023-09-30 | $-0.02B | $0.10B | -23.35% |
| 2023-06-30 | $-0.02B | $0.10B | -23.17% |
| 2023-03-31 | $-0.02B | $0.10B | -23.88% |
| 2022-12-31 | $-0.03B | $0.10B | -27.45% |
| 2022-09-30 | $-0.03B | $0.10B | -26.67% |
| 2022-06-30 | $-0.03B | $0.10B | -28.57% |
| 2022-03-31 | $-0.03B | $0.10B | -27.49% |
| 2021-12-31 | $-0.03B | $0.11B | -23.13% |
| 2021-09-30 | $-0.03B | $0.12B | -23.48% |
| 2021-06-30 | $-0.02B | $0.12B | -18.18% |
| 2021-03-31 | $-0.02B | $0.12B | -18.14% |
| 2020-12-31 | $-0.02B | $0.12B | -18.81% |
| 2020-09-30 | $-0.02B | $0.12B | -19.28% |
| 2020-06-30 | $-0.03B | $0.12B | -22.70% |
| 2020-03-31 | $-0.03B | $0.12B | -21.17% |
| 2019-12-31 | $-0.03B | $0.13B | -21.98% |
| 2019-09-30 | $-0.03B | $0.14B | -19.96% |
| 2019-06-30 | $-0.03B | $0.14B | -18.09% |
| 2019-03-31 | $-0.03B | $0.14B | -17.69% |
| 2018-12-31 | $-0.02B | $0.15B | -18.76% |
| 2018-09-30 | $-0.02B | $0.15B | -21.90% |
| 2018-06-30 | $-0.02B | $0.15B | -32.54% |
| 2018-03-31 | $-0.01B | $0.02B | -69.57% |
| 2017-12-31 | $-0.01B | $0.03B | -67.80% |
| 2017-09-30 | $-0.01B | $0.01B | -114.29% |
| 2017-06-30 | $-0.01B | $0.01B | -143.59% |
| 2017-03-31 | $-0.02B | $0.01B | -193.55% |
| 2016-12-31 | $-0.02B | $0.02B | -250.00% |
| 2016-09-30 | $-0.01B | $0.00B | -305.88% |
| 2016-06-30 | $-0.01B | $0.00B | -207.41% |
| 2016-03-31 | $-0.01B | $0.01B | -280.00% |
| 2015-12-31 | $-0.01B | $0.01B | -400.00% |
| 2015-09-30 | $-0.02B | $0.01B | 1280.00% |
| 2015-06-30 | $-0.02B | $0.00B | 246.15% |
| 2015-03-31 | $-0.02B | $0.00B | 234.48% |
| 2014-12-31 | $-0.02B | $-0.01B | 212.50% |
| 2014-09-30 | $-0.02B | $-0.01B | 285.71% |
| 2014-06-30 | $-0.02B | $-0.01B | 914.29% |
| 2014-03-31 | $-0.02B | $0.00B | 666.67% |
| 2013-12-31 | $-0.01B | $0.00B | 509.09% |
| 2013-09-30 | $-0.01B | $0.00B | 400.00% |
| 2013-06-30 | $-0.01B | $-0.01B | 282.35% |
| 2013-03-31 | $-0.01B | $-0.01B | 800.00% |
| 2012-12-31 | $-0.01B | $0.00B | -720.00% |
| 2012-09-30 | $-0.01B | $0.00B | -200.00% |
| 2012-06-30 | $-0.01B | $0.00B | -152.38% |
| 2012-03-31 | $-0.01B | $0.00B | -120.00% |
| 2011-12-31 | $-0.01B | $0.01B | -108.11% |
| 2011-09-30 | $-0.01B | $0.01B | -273.68% |
| 2011-06-30 | $-0.01B | $0.01B | -209.52% |
| 2011-03-31 | $-0.01B | $0.01B | -180.00% |
| 2010-12-31 | $-0.01B | $-0.01B | -120.00% |
| 2010-09-30 | $0.01B | $0.01B | 130.23% |
| 2010-06-30 | $0.02B | $0.01B | 181.82% |
| 2010-03-31 | $0.02B | $0.01B | 272.73% |
| 2009-12-31 | $0.02B | $0.01B | 545.45% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.763B | $0.187B |
| AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $190.614B | 83.49 |
| Thermo Fisher Scientific (TMO) | United States | $159.404B | 19.28 |
| Alcon (ALC) | Switzerland | $48.032B | 31.93 |
| Edwards Lifesciences (EW) | United States | $44.155B | 28.89 |
| IDEXX Laboratories (IDXX) | United States | $38.206B | 43.91 |
| DexCom (DXCM) | United States | $31.474B | 48.65 |
| IQVIA Holdings (IQV) | United States | $26.853B | 14.86 |
| Mettler-Toledo (MTD) | United States | $22.677B | 26.97 |
| STERIS (STE) | Ireland | $22.038B | 25.20 |
| Waters (WAT) | United States | $20.727B | 29.35 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.648B | 0.00 |
| Hologic (HOLX) | United States | $11.751B | 12.77 |
| Sysmex ADR (SSMXY) | Japan | $11.664B | 0.00 |
| Penumbra (PEN) | United States | $11.352B | 89.10 |
| Globus Medical (GMED) | United States | $9.697B | 22.45 |
| Masimo (MASI) | United States | $8.800B | 36.93 |
| Teleflex (TFX) | United States | $5.431B | 8.96 |
| Glaukos (GKOS) | United States | $4.963B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.067B | 21.31 |
| TransMedics (TMDX) | United States | $3.119B | 91.30 |
| PROCEPT BioRobotics (PRCT) | United States | $3.010B | 0.00 |
| Veracyte (VCYT) | United States | $2.453B | 44.11 |
| Nihon Kohden (NHNKY) | Japan | $2.160B | 11.81 |
| LivaNova (LIVN) | United Kingdom | $1.978B | 11.97 |
| Elekta AB (EKTAY) | Sweden | $1.956B | 17.59 |
| Alphatec Holdings (ATEC) | United States | $1.751B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.418B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.116B | 0.00 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.026B | 5.49 |
| Artivion (AORT) | United States | $1.015B | 95.08 |
| IRadimed (IRMD) | United States | $0.665B | 33.74 |
| Mesa Laboratories (MLAB) | United States | $0.644B | 14.08 |
| SiBone (SIBN) | United States | $0.606B | 0.00 |
| RxSight (RXST) | United States | $0.595B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.561B | 9.03 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.528B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.512B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.506B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.460B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.401B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.388B | 0.00 |
| NeuroPace (NPCE) | United States | $0.378B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.366B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.333B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.330B | 19.63 |
| Semler Scientific (SMLR) | United States | $0.322B | 6.84 |
| Neuronetics (STIM) | United States | $0.296B | 0.00 |
| CVRx (CVRX) | United States | $0.203B | 0.00 |
| 908 Devices (MASS) | United States | $0.193B | 0.00 |
| Inogen (INGN) | United States | $0.187B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.183B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.169B | 0.00 |
| LENSAR (LNSR) | United States | $0.164B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.151B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.147B | 0.00 |
| Accuray (ARAY) | United States | $0.135B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.132B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.127B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.114B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.099B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.097B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.087B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.080B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.067B | 10.18 |
| EnVVeno Medical (NVNO) | United States | $0.063B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.054B | 0.00 |
| Hyperfine (HYPR) | United States | $0.052B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.050B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.036B | 0.00 | |
| Biosig Technologies (BSGM) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.34 |